Value of 18 F-FDG PET/CT for prognosis evaluation in small cell lung cancer with normal serum lac-tate dehydrogenase
10.3760/cma.j.issn.2095-2848.2017.10.001
- VernacularTitle:18 F-FDG PET/CT对血清乳酸脱氢酶正常的小细胞肺癌预后的预测价值
- Author:
Xiaoping LIN
1
;
Yingying HU
;
Xu ZHANG
;
Peiyan LIANG
;
Wei FAN
Author Information
1. 中山大学肿瘤防治中心核医学科
- Keywords:
Small cell lung carcinoma;
Prognosis;
Lactate dehydrogenases;
Positron-emission tomography;
Tomography,X-ray computed;
Deoxyglucose
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2017;37(10):601-606
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the value of 18 F-FDG PET/CT imaging in predicting the progno-sis of newly diagnosed SCLC with normal serum LDH ( SCLC-nsLDH) . Methods A total of 68 SCLC pa-tients (59 males, 9 females, median age:58.5 years) proved by pathology between June 2005 and Decem-ber 2016 were retrospectively analyzed. All patients underwent 18 F-FDG PET/CT. The general information of patients, including LDH, NSE, OS, PFS and SUVmax , were recorded. SUVmax differences were analyzed with Mann-Whitney u test. Life-table method and Kaplan-Meier analysis were used to estimate the survival rate and median survival time. The survival function curve was drawn. Log-rank test was used to analyze whether there existed statistical differences in survival period among different groups. Cox regression analysis was used for screening the influencing factors of prognosis. Results ( 1) In 68 SCLC patients, there were 38 cases with limited disease ( LD) and 30 cases with extensive disease ( ED) . There were 3 cases in stageⅠ, 7 cases in stage Ⅱ, 29 cases in stage Ⅲ, 29 cases in stage Ⅳ. The median SUVmax of the primary tumor was 11.35 (9.90, 13.90). There was no significant difference between the median SUVmax of LD group and that of ED group:11.05(9.72, 13.60) vs 12.25(10. 05, 14.12)months;z=-0.797, P=0.426. The median serum LDH was 195.15(171.00, 220.80) U/L. (2) The median follow-up time was 18(range:2-101) months. The disease developed in 46 patients and 35 patients died. The median OS was 23 (95%CI:13.3-32.7) months and median PFS was 17 (95% CI: 11.4-22.6) months. (3) ROC curve showed the optimal SUVmax cutoff value was 10.85. The OS of patients with SUVmax≤10.85 ( n=25) and with SUVmax>10.85 (n=43) were 40.0(95% CI:2.5-77.5) months and 18.0(95% CI:13.3-22.7) months(χ2=8.956, P=0.003), respectively. (4)Weight loss, VALG stage and primary tumor SUVmax were independent prog-nostic factors for OS (all P<0.05). Only VALG stage was an independent prognostic factor for PFS (P<0. 001) . Conclusion 18 F-FDG PET/CT can help to differentiate the different prognosis of SCLC-nsLDH patients, and provide more evidence for the choice of individual treatment strategy.
